Concepedia

Tumor Marker Validation

Tumor Marker Validation is the systematic process of assessing the clinical utility, reliability, and specificity of a biomarker through analytical, diagnostic, and prognostic evaluation to confirm its effectiveness in detecting or monitoring cancer.

227

Publications

12.8K

Citations

1.5K

Authors

532

Institutions

Publications per year

2017–2026

33

Parents

Publications

227

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard Simon, Seungmok Paik, Daniel F. Hayes · JNCI Journal of the National Cancer Institute · 2009 · 1K citations · Full text

, , +17

Reporting Recommendations for Tumor Marker Prognostic Studies

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · Journal of Clinical Oncology · 2005 · 775 citations · Full text

, , +17

The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal.

Umashankar K. Ballehaninna, Ronald S. Chamberlain · PubMed · 2012 · 700 citations · Full text

, , +17

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

Merle Hanke, Kai P. Hoefig, Hartmut Merz et al. · Urologic Oncology Seminars and Original Investigations · 2009 · 637 citations

, , +17

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Pedram Argani, Christine A. Iacobuzio–Donahue, Byungwoo Ryu et al. · PubMed · 2001 · 578 citations

, , +13

1–5 of 227

Authors

1.5K

  1. RM
    Rafael Molina

    Universidad de Granada, Spain

    3 publications · 243 citations

    3

    h-index

  2. MG
    Maria Grazia Daidone

    Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

    3 publications · 81 citations

    3

    h-index

  3. MG
    Massimo Gion

    Istituti di Ricovero e Cura a Carattere Scientifico, Italy

    3 publications · 805 citations

    3

    h-index

  4. KV
    Katja von Hoff

    University Medical Center Hamburg-Eppendorf, Germany

    2 publications · 110 citations

    2

    h-index

  5. NM
    Norimasa Miura

    Tottori University, Japan

    2 publications · 105 citations

    2

    h-index

1–5 of 1.5K

Institutions

532

  1. National Cancer Institute

    Bethesda, United States

    7 h-index

    25 publications

    5.8K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    5 h-index

    21 publications

    746 citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    5 h-index

    8 publications

    266 citations

  4. Heidelberg University

    Heidelberg, Germany

    4 h-index

    11 publications

    304 citations

  5. Sun Yat-sen University

    Guangzhou, China

    4 h-index

    14 publications

    550 citations

  6. Gunma University

    Maebashi, Japan

    3 h-index

    15 publications

    674 citations

  7. Memorial Hospital of South Bend

    South Bend, United States

    3 h-index

    6 publications

    126 citations

  8. Keio University

    Tokyo, Japan

    3 h-index

    7 publications

    153 citations

1–8 of 532

Venues

  1. PubMed

    Repository · 26 publications · 2K citations

    18

    h-index

  2. The International Journal of Biological Markers

    JBM · 7 publications · 133 citations

    7

    h-index

  3. Gynecologic Oncology

    6 publications · 178 citations

    6

    h-index

  4. Clinica Chimica Acta

    CCA · 6 publications · 610 citations

    6

    h-index

  5. Urology

    5 publications · 268 citations

    5

    h-index

1–5